Finally, the persistence of the ancestral RKLP sequence and its predominant expression in humans of African descent suggest that this human polymorphism may contribute to the racial disparities in diseases associated with GPRC6A, including Metabolic Syndrome [56] and prostate cancer [57]. Here, GPRC6A is linked to prostate carcinoma.